Innate Immune Responses in the CNS: Role of Toll-Like Receptors, Mechanisms, and Therapeutic Opportunities in Multiple Sclerosis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Neuroimmune Pharmacology

• Publication date

  2013-06-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11481-013-9483-3PMID 23812895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EBV stimulates TLR‐ and autophagy‐dependent pathways and impairs maturation in plasmacytoid dendritic cells: Implications for viral immune escape

  2013influential reference
• Environmental risk factors for multiple sclerosis

  2013cited by this paper
• Treatment of Autoimmune Inflammation by a TLR7 Ligand Regulating the Innate Immune System

  2012cited by this paper
• A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome

  2012cited by this paper
• Dissecting negative regulation of Toll-like receptor signaling.

  2012cited by this paper
• PAMPs and DAMPs: signal 0s that spur autophagy and immunity

  2012cited by this paper
• Regulation of TLR7/9 signaling in plasmacytoid dendritic cells

  2012influential reference
• Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs

  2012cited by this paper
• The innate immune system in demyelinating disease

  2012cited by this paper
• A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression

  2012cited by this paper
• TLRs as miRNA receptors.

  2012cited by this paper
• IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells.

  2011cited by this paper
• Interferon-β Inhibits Toll-Like Receptor 9 Processing in Multiple Sclerosis

  2011cited by this paper
• Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.

  2011cited by this paper
• Implication of the toll‐like receptor 4 pathway in the response to interferon‐β in multiple sclerosis

  2011cited by this paper
• TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function

  2011cited by this paper
• TLR based therapeutics.

  2011influential reference
• Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

  2011cited by this paper
• Regulation of remyelination in multiple sclerosis

  2011cited by this paper
• Letter to the Glyco-Forum: Since there are PAMPs and DAMPs, there must be SAMPs? Glycan “self-associated molecular patterns” dampen innate immunity, but pathogens can mimic them

  2011cited by this paper
• Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

  2011cited by this paper
• Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

  2011cited by this paper
• EAE: imperfect but useful models of multiple sclerosis.

  2011cited by this paper
• TLR2 polymorphisms influence neonatal regulatory T cells depending on maternal atopy

  2011cited by this paper
• TLR-dependent T cell activation in autoimmunity

  2011cited by this paper
• Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients

  2010cited by this paper
• The Microtubule Regulator Stathmin Is an Endogenous Protein Agonist for TLR3

  2010cited by this paper
• Viral Inhibitory Peptide of TLR4, a Peptide Derived from Vaccinia Protein A46, Specifically Inhibits TLR4 by Directly Targeting MyD88 Adaptor-Like and TRIF-Related Adaptor Molecule

  2010cited by this paper
• The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis.

  2010cited by this paper
• Discovery of a novel TLR2 signaling inhibitor with anti-viral activity.

  2010influential reference
• Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2

  2010cited by this paper
• Interferon‐β inhibits toll‐like receptor 9 processing in multiple sclerosis

  2010cited by this paper
• Human TLRs 10 and 1 Share Common Mechanisms of Innate Immune Sensing but Not Signaling

  2010cited by this paper
• Induction of IDO-1 by Immunostimulatory DNA Limits Severity of Experimental Colitis

  2010cited by this paper
• TLR8 deficiency leads to autoimmunity in mice.

  2010cited by this paper
• Pattern recognition receptors and inflammation.

  2010cited by this paper
• Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling

  2010cited by this paper
• The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

  2010cited by this paper
• Deciphering the complexity of Toll-like receptor signaling

  2010cited by this paper
• Multiple Sclerosis the Dysfunctional Immune Regulation in Plasmacytoid Dendritic Cells Characterizes Phenotypically Different Subsets of An Imbalance of Two Functionally and

  2010cited by this paper
• Differential but Direct Abolishment of Human Regulatory T Cell Suppressive Capacity by Various TLR2 Ligands

  2010influential reference
• IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis

  2010cited by this paper
• Epstein–Barr Virus Infection and Multiple Sclerosis: A Review

  2010cited by this paper
• TLR9 Contributes to the Recognition of EBV by Primary Monocytes and Plasmacytoid Dendritic Cells

  2010cited by this paper
• Endogenous ligands of TLR2 and TLR4: agonists or assistants?

  2010cited by this paper
• Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look.

  2010cited by this paper
• TLR3 agonists as immunotherapeutic agents.

  2010cited by this paper
• Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease.

  2010cited by this paper
• Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis.

  2010cited by this paper
• Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt

  2009cited by this paper
• The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex

  2009cited by this paper
• A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

  2009cited by this paper
• The EBV-Encoded dUTPase Activates NF-κB through the TLR2 and MyD88-Dependent Signaling Pathway1

  2009influential reference
• Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone

  2009cited by this paper
• Genetic Variation of the Human Urinary Tract Innate Immune Response and Asymptomatic Bacteriuria in Women

  2009cited by this paper
• Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

  2009cited by this paper
• Modulation of regulatory T cells in health and disease: role of toll-like receptors.

  2009cited by this paper
• Myeloid heme oxygenase–1 regulates innate immunity and autoimmunity by modulating IFN-β production

  2009cited by this paper
• Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer

  2009cited by this paper
• Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

  2009cited by this paper
• IL-17-producing human peripheral regulatory T cells retain suppressive function.

  2009cited by this paper
• The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway.

  2009influential reference
• IFN-β1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation1

  2009cited by this paper
• Initiation and Progression of Axonopathy in Experimental Autoimmune Encephalomyelitis

  2009cited by this paper
• Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7

  2009cited by this paper
• Toll-like receptors and innate immunity.

  2009cited by this paper
• Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE

  2009cited by this paper
• Helminth Antigens Modulate Immune Responses in Cells from Multiple Sclerosis Patients through TLR2-Dependent Mechanisms1

  2009cited by this paper
• Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis

  2008cited by this paper
• Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1

  2008cited by this paper
• Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2

  2008cited by this paper
• The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice.

  2008cited by this paper
• Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis.

  2008cited by this paper
• TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity1

  2008cited by this paper
• Plasmacytoid Dendritic Cells in Multiple Sclerosis: Intracerebral Recruitment and Impaired Maturation in Response to Interferon-&bgr;

  2008cited by this paper
• TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity.

  2008cited by this paper
• Role of the innate immune system in autoimmune inflammatory demyelination.

  2008cited by this paper
• Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis

  2008cited by this paper
• Signaling by Toll-like Receptors 8 and 9 Requires Bruton's Tyrosine Kinase*

  2007cited by this paper
• Multiple sclerosis: a battle between destruction and repair

  2007cited by this paper
• Environmental risk factors for multiple sclerosis. Part I: The role of infection

  2007cited by this paper
• Molecular Mimicry in Multiple Sclerosis

  2007cited by this paper
• The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

  2007cited by this paper
• Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia.

  2007cited by this paper
• Treatment of lupus‐prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms

  2007cited by this paper
• Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis.

  2007cited by this paper
• Epstein-Barr virus and multiple sclerosis

  2007cited by this paper
• IRAK-2 Participates in Multiple Toll-like Receptor Signaling Pathways to NFκB via Activation of TRAF6 Ubiquitination*

  2007cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Agonists Suppress the Production of IL-12 Family Cytokines by Activated Glia1

  2007influential reference
• Ibudilast (AV-411)

  2007cited by this paper
• Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children

  2007cited by this paper
• Toll‐like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells

  2007cited by this paper
• Epstein-Barr Virus Induces MCP-1 Secretion by Human Monocytes via TLR2

  2007cited by this paper
• The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation.

  2006cited by this paper
• Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis.

  2006cited by this paper
• Cutting Edge: TLR3 Stimulation Suppresses Experimental Autoimmune Encephalomyelitis by Inducing Endogenous IFN-β1

  2006cited by this paper
• Multiple sclerosis--the plaque and its pathogenesis.

  2006cited by this paper
• Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells.

  2006cited by this paper
• Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling.

  2006cited by this paper
• Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity.

  2006influential reference

• Global transcriptome profiling of blood mononuclear cells from individuals with radiologically isolated syndrome reveals abnormalities characteristic of the rapid manifestation of multiple sclerosis symptoms

  2024cites this paper
• The role of toll‐like receptors in immune tolerance induced by Helicobacter pylori infection

  2023cites this paper
• The Role of Substance P in Neurodegenerative Diseases

  2020cites this paper
• Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications.

  2019cites this paper
• Molecular determinants as therapeutic targets in cancer chemotherapy: An update.

  2019cites this paper
• 3,6-Dihydroxyflavone: A Potent Inhibitor with Anti-Inflammatory Activity Targeting Toll-like Receptor 2

  2018cites this paper
• Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties.

  2018cites this paper
• Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway

  2018cites this paper
• Toll‐like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection

  2017cites this paper
• Innate immune regulation of autoimmunity in multiple sclerosis: Focus on the role of Toll-like receptor 2.

  2017cites this paper
• Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis.

  2016cites this paper
• Helicobacter pylori , Experimental Autoimmune Encephalomyelitis, and Multiple Sclerosis

  2016cites this paper
• Substance P and Antagonists of the Neurokinin-1 Receptor in Neuroinflammation Associated with Infectious and Neurodegenerative Diseases of the Central Nervous System.

  2016cites this paper
• Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis

  2015cites this paper
• A Toll-Like Receptor 3-Agonist as Promising Candidate in Multiple Sclerosis Treatment

  2015influential citation
• Inflammation in neurodegenerative diseases – an update

  2014cites this paper
• Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.

  2014cites this paper